CareDx is a molecular diagnostics company that develops tests for transplant patients. It lobbies Congress on living organ donation policies and insurance coverage for new transplant diagnostic tests. Filings show they used a firm called Cura Strategies and listed health-related issues in each report. The reports show no lobbying spending was reported.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
SCOTT C LEEZER
The latest disclosures for this client.
CURA STRATEGIES
3TCURA STRATEGIES
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CURA STRATEGIES
PATRICK MEADE
CURA STRATEGIES
CURA STRATEGIES
Q1